Ascendis Pharma AS (ASND) - Stock Price & Dividends
Exchange: USA Stocks • Country: Denmark • Currency: USD • Type: Common Stock • ISIN: US04351P1012
Ascendis Pharma A/S, a biopharmaceutical company, is dedicated to creating treatments for medical conditions that currently lack effective therapies. One of its notable offerings is SKYTROFA, a solution designed for individuals with growth hormone deficiency (GHD).
Aside from SKYTROFA, Ascendis Pharma AS is actively working on a diverse portfolio consisting of three unique endocrinology rare disease products that are in various stages of clinical development. Moreover, the company is committed to the progress of oncology treatment initiatives.
Established in 2006, Ascendis Pharma AS has its headquarters in Hellerup, Denmark. To learn more about the company and its mission, visit their website: https://ascendispharma.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
ASND Stock Overview
| Market Cap in USD | 8,372m |
| Sector | Healthcare |
| Industry | Biotechnology |
| GiC SubIndustry | Biotechnology |
| TER | 0.00% |
| IPO / Inception | 2015-01-28 |
ASND Stock Ratings
| Growth 5y | 1.05 |
| Fundamental | -6.00 |
| Dividend | - |
| Rel. Performance vs Sector | 5.06 |
| Analysts | 4.38/5 |
| Fair Price Momentum | 167.95 USD |
| Fair Price DCF | - |
ASND Dividends
| Yield 12m | 0.00% |
| Yield on Cost 5y | 0.00% |
| Dividends CAGR 5y | 0.00% |
| Payout Consistency | 0.0% |
ASND Growth Ratios
| Growth 12m | 69.70% |
| Growth Correlation 12m | 65% |
| Growth Correlation 3m | 29% |
| CAGR 5y | 5.23% |
| Sharpe Ratio 12m | 1.45 |
| Alpha vs SP500 12m | 51.21 |
| Beta vs SP500 5y weekly | 0.74 |
| ValueRay RSI | 5.12 |
| Volatility GJR Garch 1y | 45.01% |
| Price / SMA 50 | -5.2% |
| Price / SMA 200 | 23.26% |
| Current Volume | 222.2k |
| Average Volume 20d | 297.6k |
External Links for ASND Stock
News
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X (Twitter) • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X (Twitter) • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
What is the price of ASND stocks?
As of April 19, 2024, the stock is trading at USD 140.89 with a total of 222,169 shares traded.
Over the past week, the price has changed by -6.72%, over one month by -4.20%, over three months by +5.95% and over the past year by +73.34%.
As of April 19, 2024, the stock is trading at USD 140.89 with a total of 222,169 shares traded.
Over the past week, the price has changed by -6.72%, over one month by -4.20%, over three months by +5.95% and over the past year by +73.34%.
What is the forecast for ASND stock price target?
According to ValueRays Forecast Model, ASND Ascendis Pharma AS will be worth about 185.6 in April 2025. The stock is currently trading at 140.89. This means that the stock has a potential upside of +31.75%.
According to ValueRays Forecast Model, ASND Ascendis Pharma AS will be worth about 185.6 in April 2025. The stock is currently trading at 140.89. This means that the stock has a potential upside of +31.75%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 0.3 | -99.8% |
| Analysts Target Price | 0.3 | -99.8% |
| ValueRay Target Price | 185.6 | 31.7% |